What the evidence says. Several controlled trials; effects real but modest or context-dependent.
What is Bifidobacterium longum BB536?
Bifidobacterium longum BB536 (Bifidobacterium longum BB536 (Morinaga)) is a probiotic strain used for eases japanese cedar pollen allergy symptoms (ocular and nasal) and suppresses pollen-driven tarc/th2 chemokine rises. NutriDex grades the human evidence as Moderate. Bifidobacterium longum BB536 (Morinaga), isolated from a healthy infant in 1969, is one of the most extensively studied probiotic strains, with its best-supported indication being allergic rhinitis from Japanese cedar pollinosis: multiple double-blind RCTs show it modestly eases nasal and ocular symptoms and blunts pollen-driven rises in Th2-attracting chemokines. Smaller RCTs also support improved bowel regularity in constipated adults/elderly, induction of remission as adjunctive therapy in mild-to-moderate ulcerative colitis (endoscopic/Mayo subscore improvement, though primary clinical-remission endpoints often miss significance), and reduced influenza incidence/fever and preserved NK-cell activity in elderly. A large pediatric RCT found reduced respiratory-illness duration but no diarrhea benefit. Effects are real but generally modest and indication-specific.
Purported Benefits
✓Eases Japanese cedar pollen allergy symptoms (ocular and nasal) and suppresses pollen-driven TARC/Th2 chemokine rises
✓Improves stool frequency and bowel regularity in adults and elderly with constipation
✓Adjunct in mild-to-moderate ulcerative colitis: improves endoscopic and Mayo subscores
✓Reduces influenza incidence and fever and preserves NK-cell activity in elderly
✓Shortens duration of upper-respiratory symptoms (e.g. sore throat) in pre-school children
✓Modulates gut microbiota, increasing beneficial Faecalibacterium abundance
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
Typically 1x10^10 to 5x10^10 CFU/day for allergy/gut/immune indications (up to 2-3x10^11 CFU/day in ulcerative colitis trials); freeze-dried powder, capsules, or fermented milk, taken once or twice daily, ideally for several weeks (allergy trials pre-load before/through pollen season).
Active Compounds
Bifidobacterium longum subsp. longum BB536 (ATCC BAA-999 / Morinaga)Used in BIfidobacterium triple mixes (BB536 + B. breve M-16V + B. infantis M-63)Freeze-dried powder, capsules, fermented-milk/yogurt formatsFDA GRAS and EFSA QPS-listed; used in infant formula
Safety & Cautions
⚠
Very well tolerated with a long history of safe use; FDA GRAS (including infant formula) and EFSA QPS status, with no serious adverse events across pediatric, elderly, pregnant, and immunosuppressed-medication populations. Mild, transient gas or bloating may occur on initiation. As with any live probiotic, exercise caution in critically ill, severely immunocompromised patients, or those with central venous catheters or compromised gut barriers, where rare bacteremia risk cannot be excluded. Educational only — always check with your doctor or pharmacist before combining Bifidobacterium longum BB536 with any medicine.
Common questions about Bifidobacterium longum BB536
What is Bifidobacterium longum BB536 used for?
Bifidobacterium longum BB536 is most often taken for Eases Japanese cedar pollen allergy symptoms (ocular and nasal) and suppresses pollen-driven TARC/Th2 chemokine rises, Improves stool frequency and bowel regularity in adults and elderly with constipation, Adjunct in mild-to-moderate ulcerative colitis: improves endoscopic and Mayo subscores, Reduces influenza incidence and fever and preserves NK-cell activity in elderly. A long-studied Japanese Bifidobacterium with the strongest data in cedar-pollen allergy and gut regularity
Does Bifidobacterium longum BB536 work — what does the evidence say?
Moderate evidence. Several controlled trials; effects real but modest or context-dependent. Bifidobacterium longum BB536 (Morinaga), isolated from a healthy infant in 1969, is one of the most extensively studied probiotic strains, with its best-supported indication being allergic rhinitis from Japanese cedar pollinosis: multiple double-blind RCTs show it modestly eases nasal and ocular symptoms and blunts pollen-driven rises in Th2-attracting chemokines. Smaller RCTs also support improved bowel regularity in constipated adults/elderly, induction of remission as adjunctive therapy in mild-to-moderate ulcerative colitis (endoscopic/Mayo subscore improvement, though primary clinical-remission endpoints often miss significance), and reduced influenza incidence/fever and preserved NK-cell activity in elderly. A large pediatric RCT found reduced respiratory-illness duration but no diarrhea benefit. Effects are real but generally modest and indication-specific.
What is the typical dose of Bifidobacterium longum BB536?
Typically 1x10^10 to 5x10^10 CFU/day for allergy/gut/immune indications (up to 2-3x10^11 CFU/day in ulcerative colitis trials); freeze-dried powder, capsules, or fermented milk, taken once or twice daily, ideally for several weeks (allergy trials pre-load before/through pollen season).
Is Bifidobacterium longum BB536 safe? Any cautions or side effects?
Very well tolerated with a long history of safe use; FDA GRAS (including infant formula) and EFSA QPS status, with no serious adverse events across pediatric, elderly, pregnant, and immunosuppressed-medication populations. Mild, transient gas or bloating may occur on initiation. As with any live probiotic, exercise caution in critically ill, severely immunocompromised patients, or those with central venous catheters or compromised gut barriers, where rare bacteremia risk cannot be excluded.
How many studies support Bifidobacterium longum BB536?
NutriDex cites 11 sources for Bifidobacterium longum BB536, graded "Moderate".
Cite this page
APA
Peh, D. (2026). Bifidobacterium longum BB536 (Bifidobacterium longum BB536 (Morinaga)): Benefits, Dosage, Side Effects & Evidence. NutriDex — The Supplement Research Compendium. Retrieved 16 Sept 2026, from https://nutridex.info/s/bifido-longum-bb536
BibTeX
@misc{nutridex_bifido_longum_bb536,
author = {Peh, Daryl},
title = {Bifidobacterium longum BB536 (Bifidobacterium longum BB536 (Morinaga)): Benefits, Dosage, Side Effects \& Evidence},
year = {2026},
howpublished = {NutriDex --- The Supplement Research Compendium},
url = {https://nutridex.info/s/bifido-longum-bb536},
note = {Reviewed by Dr Daryl Peh, MBBS Singapore, MMed FM. Accessed 2026-09-16}
}
For medical claims, citing the underlying primary studies linked above is preferred. NutriDex is an educational reference, not medical advice.